Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept of single-application investigational otic in pediatric acute otitis media
2017-002689-30Phase 2
- Sponsor
- Alcon Inc.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of finafloxacin + dexamethasone in acute otitis media (AOM) (2 arms), sponsored by Alcon Inc. Primary endpoint: Sustained clinical cure at Day 3.
02
Drugs
finafloxacin + dexamethasone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2017-002689-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002689-30.